TickerFacts.

Starling Oncology, Inc. (STLN): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$6.94M
Year ended 2025-12-31
$6.81M
Trailing 12 months to 2026-06-30
+16.3%
3-year compound annual growth
+16.9%
5-year compound annual growth
2020-12-31: $3.18M2021-12-31: $3.34M2022-12-31: $4.41M2023-12-31: $5.87M2024-12-31: $6.29M2025-12-31: $6.94M$6.94M
2020-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$6.94M+10.5%2026-03-12, From 2025-01-01
2024-12-31$6.29M+7.0%2026-03-12, From 2024-01-01
2023-12-31$5.87M+33.1%2025-03-26, From 2023-01-01
2022-12-31$4.41M+32.0%2024-03-28, From 2022-01-01
2021-12-31$3.34M+5.1%2023-03-16, From 2021-01-01
2020-12-31$3.18Mn/a2022-03-11, From 2020-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Services-Offices & Clinics of Doctors of Medicine), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
Starling Oncology, Inc. (STLN)2025-12-31$6.94M+10.5%
SBC Medical Group Holdings Inc (SBC)2025-12-31$2.68M-29.3%
Airsculpt Technologies, Inc. (AIRS)2025-12-31$12.78M+7.5%
Hims & Hers Health, Inc. (HIMS)2025-12-31$54.50M+218.9%
Cardiff Lexington Corp (CDIX)2025-12-31$5.7K-58.0%
HealthLynked Corp (HLYK)2025-12-31$101.9K-64.0%

Compare STLN, SBC, AIRS, HIMS side by side · Screen every company in Services-Offices & Clinics of Doctors of Medicine ↗